Answers are grounded in this paper and cite their sources.
Antimicrobial resistance poses a great challenge to clinicians leaving very limited treatment options available. A panel of carbapenem-resistant bacterial isolates was selected based on Rapidec Carba NP test from a total of 900 samples, which were collected from different specialities hospitals of Kanpur, India. Carba NP-positive isolates were screened for carbapenemases, extended-spectrum beta-lactamases (ESBLs), quinolone resistance, and 16s methyltransferase genes. Presence of diverse bla NDM ( bla NDM-1 and bla NDM-5 ) were detected and horizontal transferability was determined by transformation and conjugation assay. Elimination of bla NDM-1 and bla NDM-5 harboring plasmid was done by treating the isolates with sodium dodecyl sulfate. The transcriptional response of bla NDM-1 and bla NDM-5 under the exposure of imipenem, meropenem, and ertapenem stress was determined by quantitative real-time polymerase chain reaction. bla NDM harboring isolates were found to be horizontally transferable through IncF rep B and K type plasmid and could be successfully eliminated after the single treatment with sodium dodecyl sulfate. A distinct pattern of transcriptional response was observed for bla NDM-1 and bla NDM-5 under the pressure of carbapenem antibiotics where an upregulated expression of both bla NDM-1 and bla NDM-5 was observed. Minimum inhibitory concentration (MIC) results revealed that bla NDM harboring strains showed a high MIC range against imipenem, meropenem, ertapenem, cefepime, and aztreonam. Thus, prudent action should be taken to control the spread of these multidrug-resistant determinants or at least slowing down their lateral transfer in the hospital settings.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: